Validation of dual energy X-ray absorptiometry for longitudinal quantification of tumor burden in a murine model of pancreatic ductal adenocarcinoma

Validation of dual energy X-ray absorptiometry for longitudinal quantification of tumor burden in a murine model of pancreatic ductal adenocarcinoma

Show other versions (1)

Bibliographic Details
Main Authors:	Zachary R. Sechrist, Grace Lee, Edward M. Schwarz, Calvin L. Cole
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760650/?tool=EBI

Similar Items

Validation of dual energy X-ray absorptiometry for longitudinal quantification of tumor burden in a murine model of pancreatic ductal adenocarcinoma.
by: Zachary R Sechrist, et al.
Published: (2024-01-01)

Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
by: Valsecchi Matias E, et al.
Published: (2012-03-01)

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma
by: Pablo J. Dopico, et al.
Published: (2022-03-01)

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
by: Apeksha Kakkar, et al.
Published: (2016-12-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma
by: Kathrin Hedegger, et al.
Published: (2023-11-01)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
by: Raffaele Pezzilli, et al.
Published: (2011-07-01)

Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants
by: Amanda R. Decker-Farrell, et al.
Published: (2023-12-01)

The T cell architecture of pancreatic ductal adenocarcinoma
by: Sivakumar, S, et al.
Published: (2019)

The T-cell architecture of pancreatic ductal adenocarcinoma
by: Sivakumar, S, et al.
Published: (2019)

Ubiquitin signaling in pancreatic ductal adenocarcinoma
by: Shengnan Lv, et al.
Published: (2023-12-01)

Molecular imaging of pancreatic ductal adenocarcinoma
by: Wei Huang, et al.
Published: (2023-10-01)

Oral mycobiota and pancreatic ductal adenocarcinoma
by: Ailin Wei, et al.
Published: (2022-12-01)

Apoptotic pathways in pancreatic ductal adenocarcinoma
by: Saur Dieter, et al.
Published: (2008-07-01)

Metabolism remodeling in pancreatic ductal adenocarcinoma
by: Jin-Tao Li, et al.
Published: (2019-11-01)

Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
by: Ole Helm, et al.
Published: (2014-01-01)

Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
by: Yan Li, et al.
Published: (2022-01-01)

Management of Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma
by: Grace Wu, et al.
Published: (2025-02-01)

Imaging p53 in pancreatic ductal adenocarcinoma
by: Koustoulidou, S
Published: (2017)

PKM2 is not required for pancreatic ductal adenocarcinoma
by: Danai, Laura V, et al.
Published: (2018)

MORPHOLOGICAL AND EXPRESSION FEATURES OF DUCTAL PANCREATIC ADENOCARCINOMA
by: Yu. Yu. Rakina, et al.
Published: (2017-09-01)

Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
by: Jun Ushio, et al.
Published: (2021-03-01)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021-03-01)

Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma
by: Sylvia S. W. Ng, et al.
Published: (2022-12-01)

Deconvoluting cellular neighborhoods in pancreatic ductal adenocarcinoma
by: Jessica Castrillon Lal
Published: (2022-10-01)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
by: Ruining Gong, et al.
Published: (2020-03-01)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
by: Maarten F. Bijlsma, et al.
Published: (2022-04-01)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
by: Shigenori Ei, et al.
Published: (2023-09-01)

Effect of Adenomatous Polyposis Coli Loss on Tumorigenic Potential in Pancreatic Ductal Adenocarcinoma
by: Jennifer M. Cole, et al.
Published: (2019-09-01)

Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma.
by: Louise M Fanchon, et al.
Published: (2020-01-01)

Advances in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Premalignant Pancreatic Lesions
by: Reiko Yamada, et al.
Published: (2023-06-01)

Multiomic quantification of the KRAS mutation dosage improves the preoperative prediction of survival and recurrence in patients with pancreatic ductal adenocarcinoma
by: Won-Gun Yun, et al.
Published: (2025-01-01)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
by: Wang, L, et al.
Published: (2015)

Identifying genes that are required for the maintenance of pancreatic ductal adenocarcinoma
by: Jenq, Harry
Published: (2013)

Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
by: Koustoulidou, S, et al.
Published: (2016)

Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
by: Chelsae R. Watters, et al.
Published: (2025-03-01)

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
by: Peiyi Liu, et al.
Published: (2024-11-01)

Diagnosis of Pancreatic Ductal Adenocarcinoma Using Deep Learning
by: Fulya Kavak, et al.
Published: (2024-10-01)

Cellular crosstalk of regulatory T cells in pancreatic ductal adenocarcinoma
by: Xuqing Shi, et al.
Published: (2024-06-01)

Role of Endoscopic Ultrasound in Diagnosis of Pancreatic Ductal Adenocarcinoma
by: Abhirup Chatterjee, et al.
Published: (2023-12-01)